The Hidden Variable: A Case of Dasatinib-Induced Respiratory Failure

Tyrosine kinase inhibitors that target the BCR/ABL mutation have been used as therapies of BCR/ABL positive acute lymphoblastic leukemia (ALL) with significant results. Dasatinib is a multitargeted tyrosine kinase inhibitor with significant activity in Philadephia positive ALL which is resistant to...

Descripción completa

Detalles Bibliográficos
Autores principales: Drekolias, Dimitrios, Gadela, Naga Vaishnavi, Syeda, Asma, Jacob, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781781/
https://www.ncbi.nlm.nih.gov/pubmed/33415044
http://dx.doi.org/10.7759/cureus.11892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781781/
https://www.ncbi.nlm.nih.gov/pubmed/33415044
http://dx.doi.org/10.7759/cureus.11892

Ejemplares similares